Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Treasury Shares (2022 - 2026)

Aveanna Healthcare Holdings' Treasury Shares history spans 4 years, with the latest figure at $15.6 million for Q1 2026.

  • For Q1 2026, Treasury Shares rose 1.14% year-over-year to $15.6 million; the TTM value through Jan 2026 reached $15.6 million, up 1.14%, while the annual FY2026 figure was $15.6 million, 1.14% up from the prior year.
  • Treasury Shares reached $15.6 million in Q1 2026 per AVAH's latest filing, up from $15.4 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $15.6 million in Q1 2026 to a low of $2.5 million in Q1 2022.
  • Average Treasury Shares over 4 years is $10.1 million, with a median of $11.4 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: surged 123.22% in 2022, then rose 1.14% in 2026.
  • A 4-year view of Treasury Shares shows it stood at $5.5 million in 2022, then surged by 109.05% to $11.4 million in 2023, then soared by 34.92% to $15.4 million in 2024, then rose by 1.14% to $15.6 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's Treasury Shares are $15.6 million (Q1 2026), $15.4 million (Q4 2024), and $11.4 million (Q4 2023).